BRL 35135

• Description:

  BRL 35135 is a potent and selective β3-adrenergic receptor agonist. BRL 35135 can dose dependently increase energy expenditure, reduce weight, and only reduce fat without reducing muscle protein. BRL 35135 can significantly improve glucose tolerance and insulin sensitivity. BRL 35135 can be used to study metabolic conditions such as obesity and diabetes[1].

• UNSPSC:

  12352005

• Target:

  Adrenergic Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Smiles:

  COC(COC(C=C1)=CC=C1C[C@H](C)NC[C@H](C2=CC(Cl)=CC=C2)O)=O

• Molecular Formula:

  C20H24ClNO4

• Molecular Weight:

  377.86

• References & Citations:

  [1]Cawthorne MA, et al. BRL 35135, a potent and selective atypical beta-adrenoceptor agonist. Am J Clin Nutr. 1992 Jan;55 (1 Suppl) :252S-257S.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 2

• Isoform:

  β adrenergic receptor

• CAS Number:

  [86615-96-5]